Vaxxinity to present at the 2024 j.p. morgan healthcare conference

Cape canaveral, fla., jan. 03, 2024 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of medicines, today announced that mei mei hu, chief executive officer of vaxxinity, will present an update on the company and its pipeline at the 42nd annual j.p. morgan healthcare conference on thursday, january 11, 2024, at 10:30am pst.
VAXX Ratings Summary
VAXX Quant Ranking